Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), unveiled plans to expand its development and manufacturing facility at its Poway, CA location. The expansion will enable Cellipont to increase capacity for process development and Phase I/II programs.
“After months of planning we are excited to be moving forward with this facility expansion,” Deborah Wild, CEO, Cellipont Bioservices. “We are fortunate to have supportive clients who have been requesting that we grow our capacity to satisfy their advancing programs. This project marks an important first step in making that happen and we continue to work on additional capacity investments.”
